Disease Activity-Dependent Siglec-1 Expression on Monocyte Subsets of Patients with Idiopathic Inflammatory Myopathies
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26104950 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sándor Baráth und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: Sialic Acid Binding Ig-like Lectin 1, Monocytes, Myositis, Dermatomyositis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant Committee of the University of Debrecen, Scientific Publication Support Program.
Abstract (Originalsprache)
Interferon signature is one of the key pathogenic pathways in idiopathic inflammatory myopathies (IIMs), particularly in dermatomyositis (DM). The aim of this study was to analyze Siglec-1, an interferon-inducible receptor, on different monocyte subsets in IIM subtypes and investigate its association with disease activity measures. Siglec-1 expression was measured by 8-color flow cytometry in 62 IIM patients and 10 healthy controls (HC). Disease activity was assessed using the International Myositis Assessment and Clinical Studies (IMACS) core set measures. Active DM patients exhibited significantly higher Siglec-1 mean fluorescence intensity (MFI) compared to inactive subgroups and HCs in every monocyte subset. Intermediate monocytes displayed the highest Siglec-1 expression across all groups and the strongest associations between disease activity markers. Siglec-1 expression on monocyte subsets was strongly associated with global, extramuscular global, constitutional, cutaneous, muscular, and gastrointestinal activity measures, but not with pulmonary, skeletal, and cardiac activities in the DM population. The best indicator of DM global disease activity among the examined biomarkers was Siglec-1 MFI on intermediate monocytes. Siglec-1 on intermediate monocytes correlates strongly with organ-specific clinical and biochemical markers of disease activity; therefore, it is a candidate biomarker for monitoring IIM disease activity. Siglec-1 could be useful in patient selection for interferon-targeted treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
- Division of Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
ORCID-Profile: Melinda Nagy-Vincze, Katalin Szabó, Zsuzsanna Hevessy, Zoltán Griger
Förderung
- Grant Committee of the University of Debrecen, Scientific Publication Support Program
Zitieren
APA
Baráth, S., Nagy-Vincze, M., Kun, Z., Szinay, D., Griger, Z., Béldi, T. G., Szabó, K., Száraz-Széles, M., Hevessy, Z., & Griger, Z. (2025). Disease Activity-Dependent Siglec-1 Expression on Monocyte Subsets of Patients with Idiopathic Inflammatory Myopathies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104950
Vancouver
Baráth S, Nagy-Vincze M, Kun Z, Szinay D, Griger Z, Béldi TG, et al. Disease Activity-Dependent Siglec-1 Expression on Monocyte Subsets of Patients with Idiopathic Inflammatory Myopathies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104950
BibTeX
@article{Barth2025,
author = {Baráth, Sándor and Nagy-Vincze, Melinda and Kun, Zsuzsanna and Szinay, Dorottya and Griger, Zoltán and Béldi, Tibor Gábor and Szabó, Katalin and Száraz-Széles, Marianna and Hevessy, Zsuzsanna and Griger, Zoltán},
title = {Disease Activity-Dependent Siglec-1 Expression on Monocyte Subsets of Patients with Idiopathic Inflammatory Myopathies},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26104950}
}
EUVIMED